Literature DB >> 11229512

Grayanotoxin poisoning in three goats.

B Puschner1, D M Holstege, N Lamberski.   

Abstract

Six Nubian goats were exposed to an azalea branch (Rhododendron indica) at the Riverbanks Zoological Park in Columbia, South Carolina. The following day, 3 of the 6 goats were referred to the veterinary hospital of the Riverbanks Zoological Park with bloat, profuseregurgitation, and signs of depression, intermittent head pressing, and fine muscle tremors in the hind limbs. The goats were treated with magnesium hydroxide, activated charcoal, and lactated Ringer's solution and recovered within 24 hours. Definitive diagnosis of grayanotoxin exposure was accomplished by use of liquid chromatography-mass spectrometry analysis of urine and fecal samples. Rhododendron spp are members of the Ericaceae (Heath) family and may contain grayanotoxins, which exert toxic effects by binding to sodium channels in cell membranes and increasing the permeability of sodium ions in excitable membranes. Rhododendron poisoning should be considered in animals with clinical evidence of gastrointestinal tract irritation, cardiac arrhythmias, and neurologic signs.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11229512     DOI: 10.2460/javma.2001.218.573

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  3 in total

1.  Treatment of pieris ingestion in goats with intravenous lipid emulsion.

Authors:  Karyn Bischoff; Mary C Smith; Samuel Stump
Journal:  J Med Toxicol       Date:  2014-12

Review 2.  Grayanotoxin poisoning: 'mad honey disease' and beyond.

Authors:  Suze A Jansen; Iris Kleerekooper; Zonne L M Hofman; Isabelle F P M Kappen; Anna Stary-Weinzinger; Marcel A G van der Heyden
Journal:  Cardiovasc Toxicol       Date:  2012-09       Impact factor: 3.231

3.  Assessment of cytotoxicity exerted by leaf extracts from plants of the genus Rhododendron towards epidermal keratinocytes and intestine epithelial cells.

Authors:  Ahmed Rezk; Alaa Al-Hashimi; Warren John; Hartwig Schepker; Matthias S Ullrich; Klaudia Brix
Journal:  BMC Complement Altern Med       Date:  2015-10-15       Impact factor: 3.659

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.